EXCEL-LONON-ISTH-2022-HORIBA-Medical

ISTH 2022

ISTH 2022 - HORIBA Medical

Discover HORIBA Medical Hemostasis Solutions at ISTH 2022!

HORIBA Medical will showcase its hemostasis solutions at the ISTH 2022 Congress which will take place from July 9 to 13 in London. This annual ISTH Congress is the premier event in the field of thrombosis and hemostasis. It features the latest scientific breakthroughs and clinical updates. Expected visitors to the ISTH Congress are clinicians, researchers, educators, students/trainees, allied healthcare professionals and industry partners. They will be able to exchange the latest in scientific innovation and to advance the overall understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. 

During this Congress, HORIBA Medical will open an exhibition booth to showcase its high range hemostasis analyzers ideal for hospitals and large laboratories. Besides the booth, HORIBA Medical will also hold a scientific symposium presented by key opinion leaders from the UK and France.

The HORIBA Medical team is looking forward to welcoming you there!

 

Exhibition - HORIBA Medical booth

Date: From July 9 - 13, 2022
Venue: Excel, London
Booth number: #1225

ISTH 2022 HORIBA Medical Symposium

Date: Tuesday, July 12 from 12:15 pm to 1:00 pm 
Venue: Presentation theater #3, Excel, London
Registration: Click here to register
(Apart from the registration above, you will need to register for the ISTH.)

Speakers and Abstracts

1. The scientific aspects of APTT reagents in the assessment of coagulation

Dr Annette Bowyer, Department of Coagulation at Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK

APTT reagents are integral to the monitoring of unfractionated heparin, detection of lupus anticoagulants and measurement of intrinsic pathway clotting factors. This presentation will explore how the variation between APTT reagents can impact on the sensitivity to each of these areas of coagulation.

2. Analytical performances of a new immunoturbidimetric D-Dimer assay

Dr Laurie Talon – Hematology Department, University Hospital of Clermont-Ferrand - France

Widespread daily use of D-Dimer assay for exclusion of venous thromboembolism led to development of many assays. However, their usefulness depends on their reliability and performance. Evaluation of the analytical performances of the Yumizen G DDi 2 assay (Horiba Medical) performed with the Yumizen G800 analyzer and to compare it with other available D-Dimer assays: Vidas D-Dimer Exclusion II on Vidas 3 (BioMérieux), Liatest D-Di Plus on STA-R Max (Diagnostica Stago), Innovance D-dimer on CS-2100i (Siemens Healthineers) and HemoSil D-Dimer HS500 on ACLTOP700 (Werfen).

3. Diagnosing protein S deficiencies: clinical and biological aspects

Dr Pierre Suchon - INSERM UMR_S 1263, Nutrition Obesity and Risk of Thrombosis, Center for CardioVascular and Nutrition research (C2VN), Hematology Department CHU Timone, Aix-Marseille University, Marseille 13385, France

Diagnosing protein S deficiency is challenging. What is the place of protein S activity in the diagnosis strategy? What is the correlation between protein S rate and venous thrombosis risk? 

Request for Information

Do you have any questions or requests? Use this form to contact our specialists.

Corporate